[Molecular structure and abnormal expression of angiopoietin-2 and antiangiogenic targeting therapy of hepatocelluar carcinoma].
GU
Wen-jing
WJ
Affiliated Hospital of Nantong University, Nantong 226001, China.
YAO
Deng-fu
DF
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D042702:Angiopoietin-2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply / Q000378:metabolism / Q000473:pathology*; D015394:Molecular Structure; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D034622:RNA Interference; D015398:Signal Transduction / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D042702:Angiopoietin-2; D042461:Vascular Endothelial Growth Factor A